![Ed Tate](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Ed Tate
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Myricx Pharma Ltd.
![]() Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Gründer | 01.01.2019 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | 06.10.2023 |
Karriereverlauf von Ed Tate
Statistik
International
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Myricx Pharma Ltd.
![]() Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |